Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Carmustine × 90 days × Clear all

Sponsor

Conditions

Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lambert-Eaton Myasthenic Syndrome 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Enteropathy-Associated T-Cell Lymphoma 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

fludarabine 4 Cyclophosphamide 4 blinatumomab 3 Melphalan 3 pembrolizumab 2 fludarabine phosphate 2 Lenalidomide 2 Dexamethasone 2 Cytarabine 2 Capecitabine 2 venetoclax 1 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 palbociclib 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 avelumab 1 abemaciclib 1 Whole-Body Irradiation 1 Trastuzumab 1 Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡